In the News

Vesta Marciulioniene, Director, Global Regulatory Clinical Services and Jo Hulbert, Executive Director, Global Regulatory Clinical Services provide an overview of the EMA’s new framework on computerised systems and electronic data in clinical trials in this article from XTalks Clinical Edge.

This article from the Business Post reports that Icon plc has reported double-digit profit growth for the third quarter of 2023.

CFO Brendan Brennan is interviewed by Emmet Oliver on Newstalk’s Breakfast Business.

This episode of The Pharma Letter Podcast features an interview with ICON’s Chief Commercial Officer, George McMillan.

In this article in Contract Pharma provides an overview of the discussion on the recent Global Site Solutions Summit.

Recent ICON plc collaboration with Tufts CSDD on a pilot study to validate new and more granular outsourcing model classifications

This article will explore how clinical trials have become more complex with more moving parts, along with the requirements for technology specific automation.

In the ever-expanding universe of real world data, exploration and visualization strategies have become indispensable. This article presents 5 takeaways relevant to these strategies.

In this article, find out what the future holds for narrative production in clinical studies now that we are in the era of AI.

How an optimised eCOA implementation strategy can minimise several risks and challenges associated with clinical trials.